Publications

For an updated list of publications access www.ncbi.nlm.nih.gov/sites/entrez and search under "Nutting C" to get the latest papers for our research group.

Papers published or "in press" for peer-reviewed Journals

Original Articles

1. Venkitaraman R, Affolter A, Ahmed M, Thomas V, Pritchard-Jones K, Sharma AK, Marais R, Nutting CM. Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma. Acta Oncol. 2008;47:469-72

2. Kazi R, Singh A, Al-Mutairy A, de Cordova J, O'Leary L, Nutting C, Clarke P, Evans PR, Harrington K. Electroglottographic analysis of valved speech following total laryngectomy. Logoped Phoniatr Vocol. 2008;33(1):12-21

3. Nutting CM, Bhide SA, Harrington KJ. Treatment of head and neck cancer. N Engl J Med. 2008;358(10):1076-7

4. Singh A, Kazi R, Venkitaraman R, Kapoor K, Nutting C, Clarke P, Rhys Evans P, Harrington K. Does flexible videostroboscopy compare with rigid videostroboscopy in the assessment of the neoglottis? A preliminary report. Clin Otolaryngol. 2008;33(1):60-3

5. Kazi R, Venkitaraman R, Johnson C, Prasad V, Clarke P, Newbold K, Rhys-Evans P, Nutting C, Harrington K. Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiother Oncol. 2008;

6. Lee B, Cook G, Lynn J, Harrington K, Nutting C. Follicular Thyroid Carcinoma Metastasis to the Esophagus Detected by (18)FDG PET/CT. Thyroid. 2008;18(2):267-71

7. Singh A, Kazi R, De Cordova J, Nutting CM, Clarke P, Harrington KJ, Rhys Evans P. Multidimensional Assessment of Voice After Vertical Partial Laryngectomy: A Comparison With Normal and Total Laryngectomy Voice. J Voice. 2008;

8. Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Mc Nair H, Bidmead AM, Warrington J, Dearnaley DP, Harmer C, Harrington KJ, Nutting CM. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol. 2007;85(1):58-63

9. Kazi R, Venkitaraman R, Johnson C, Prasad V, Clarke P, Rhys-Evans P, Nutting CM, Harrington KJ. Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. Int J Radiat Oncol Biol Phys. 2008;70(2):344-52

10. Wechalekar K, Ng FS, Poole-Wilson PA, Duncan A, Nutting C, Naidoo VV, Underwood SR. Cardiac amyloidosis diagnosed incidentally by bone scintigraphy. J Nucl Cardiol. 2007;14(5):750-3

11. Kazi R, Prasad VM, Kanagalingam J, Georgalas C, Venkitaraman R, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Analysis of formant frequencies in patients with oral or oropharyngeal cancers treated by glossectomy. Int J Lang Commun Disord. 2007;42(5):521-32

12. Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, McNair H, Bidmead M, Warrington AP, Dearnaley DP, Harrington KJ, Nutting CM. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol. 2007;85(1):36-41

13. Bhide S, Clark C, Harrington K, Nutting CM. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Med Dosim. 2007;32(3): 188-95

14. Kazi R, Singh A, De Cordova J, Al-Mutairy A, O'leary L, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Postlaryngectomy Vocal Rehabilitation: Assessment Using a Validated Questionnaire in 51 Patients. ORL J Otorhinolaryngol Relat Spec. 2007;69:289-294

15. Kazi R, Kanagalingam J, Ventikaraman R, Prasad V, Clarke P, Nutting CM, Rhys-Evans P, Harrington KJ. Electroglottographic and Perceptual Evaluation of Tracheoesophageal Speech. J Voice. 2007:7;

16. Jankowska PJ, Kong C, Burke K, Harrington KJ, Nutting C. A systematic study of posterior cervical lymph node irradiation with electrons:Conventional versus customized planning. Radiother Oncol. 2007:28;

17. Clark CH, Miles EA, Urbano TG, Bhide S, Bidmead M, Nutting CM. Quality Assurance for an IMRT Trial: Pre-trial Exercises for PARSPORT. Clin Oncol (R Coll Radiol). 2007;19:S6.

18. Kazi RA, Prasad VM, Kanagalingam J, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Assessment of the Formant Frequencies in Normal and Laryngectomized Individuals Using Linear Predictive Coding.J Voice. 2006 Sep 27;

19. Kazi R, Prasad V, Venkitaraman R, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Questionnaire analysis of the swallowing-related outcomes following total laryngectomy. Clin Otolaryngol. 2006;31:525-30

20. Kazi R, Singh A, Mullan GP, Venkitaraman R, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Can objective parameters derived from videofluoroscopic assessment of post-laryngectomy valved speech replace current subjective measures? An e-tool-based analysis. Clin Otolaryngol. 2006;31:518-24

21. Kazi R, Kiverniti E, Prasad V, Venkitaraman R, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Multidimensional assessment of female tracheoesophageal prosthetic speech. Clin Otolaryngol. 2006;31:511-7

22. Kazi R, De Cordova J, Kanagalingam J, Venkitaraman R, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Quality of life following total laryngectomy: assessment using the UW-QOL scale. ORL J Otorhinolaryngol Relat Spec. 2007;69:100-6

23. Hu JC, Coffin RS, Davis CJ, Graham NJ, Groves N, Guest PJ, Harrington KJ, James ND, Love CA, McNeish I, Medley LC, Michael A, Pandha HS, Shorrock CA, Simpson J, Steiner J, Steven NM, Wright D, Coombes RC. A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. Clin Cancer Res 2006;12:6737-47

24. Kazi RA, Prasad VM, Kanagalingam J, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Assessment of the Formant Frequencies in Normal and Laryngectomized Individuals Using Linear Predictive Coding. J Voice. 2006:27;

25. Nutting C, Horlock N, A'Hern R, Searle A, Henk JM, Rhys-Evans P, Harrington K. Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excisionand flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol. 2006;80:39-42

26. Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, Nutting CM, Dearnaley DP, Tait DM. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys. 2006;65:907-16

27. Kazi R, Singh A, De Cordova J, Al-Mutairi A, Clarke P, Nutting C, Rhys-Evans P, Harrington KJ. Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy. Clin Otolaryngol. 2006;315:404-10

28. Kazi R, De Cordova J, Singh A, Venkitaraman R, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Voice-related Quality of Life in Laryngectomees: Assessment Using the VHI and V-RQOL Symptom Scales. J Voice. 2006 Jun 29; [Epub ahead of print]

29. Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, Nutting CM, Dearnaley DP, Tait DM. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 2006;65:907-16

30. Kirby AM, A’Hern RP, D’Ambrosio C, Tanay M, Syrigos KN, Rogers SJ, Box C, Eccles SA, Nutting CM, Harrington KJ. Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer. Br J Cancer. 2006;94:631-6

31. Kazi R, Kanalingam J, Al-Mutairi A, Nutting CM, Clarke P, Rhys-Evans P, Harrington KJ. Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol. 2006;31:83

32. Bradley PJ, Zutchi B, Nutting CM. An audit of clinical resources available for the care of head and neck cancer patients in England. J Laryngol Otol. 2005;119:620-6

33. Nutting CM, Shah-Desai S, Rose GE, Norton AP, and Plowman PN. Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma. Eye 2005 Aug

34. Humphreys M, Guerrero Urbano MT, Mubata C, Miles E, Harrington KJ, Bidmead M, and Nutting CM. CTV to PTV margin determination: Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging. Radiother Oncol. 2005;77:39-44

35. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, Gadd J, Jarrington J, Bidmead M, Horwich A. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer. 2005;92(3):488-98.

36. Harrington KJ, A’Hern R, Eisen T, Nutting C, Gore M. Patient selection for palliative whole-brain radiotherapy based on RTOG recursive partitioning analysis. Clin Oncol (R Coll Radiol). 2005;17(2):128

37. Harrington KJ, Michalaky VJ, Vini L, Nutting CM, Syrigos K, A’Hern R, Harmer CL. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience. Br J Radiol. 2005;78(929):405-10.

38. S Flampouri, H McNair, EM Donovan, PM Evans, M Partridge, F Verhaegen , CM Nutting. Initial patient imaging with an optimised radiotherapy beam for portal imaging. Radiother Oncol. 2005;76(1):63-71

39. Morris SL, Low SH, A'Hern RP, Eisen TG, Gore ME, Nutting CM, Harrington KJ. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma.Br J Cancer. 2004;91:829-33.

40. Mendes RL, Nutting CM, Harrington KJ. Residual or recurrent head and neck cancer presenting with nerve root compression affecting the upper limbs. Br J Radiol. 2004;77:688-90.

41. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol. 2004;70:189-98.

42. Adams EJ, Convery DJ, Cosgrove VP, McNair HA, Staffurth JN, Vaarkamp J, Nutting CM, Warrington AP, Webb S, Balyckyi J, Dearnaley DP. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol. 2004;70:1-10.

43. McNair HA, Parker C, Hansen VN, Askew L, Mukherjee R, Nutting C, Norman AR, Dearnaley DP.An evaluation of Beam cath in the verification process for prostate cancer radiotherapy.
Clin Oncol. 2004;16:138-47.

44. Harrington KJ, A’Hern R, Eisen T, Nutting C, Gore M. Patient selection for palliative whole brain radiotherapy based on RTOG recursive partitioning analysis. Clinical Oncology 2004;10:128

45. Bolton S and Nutting C. Head and Neck Cancer: Advances in Radiotherapy Planning, Treatment and Future Developments. Clinical Oncology 2004;16(7):S1-S14

46. Panakis N, Nutting C. Radical treatment of non-small cell lung cancer: a meeting of The British Institute of Radiology, held at The Royal Marsden Hospital, Thursday 5th February 2004. Br J Radiol. 2004;77:807-10

47. Nutting C, Harrington K. In regards to Dr. Glatstein Int J Radiat Oncol Biol Phys 2003;55:561-562, and Dr. Amols, Int J Radiat Oncol Biol Phys 2003;56:1507. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1316-7

48. Harrington KJ, Nutting CM, Archer DJ. Re: Rowland NH and Schnetler JF. Primary malignant melanoma arising in the dorsum of the tongue. Br J Oral Maxillofac Surg. 2004;42:78-9

49. Michalaki VJ, Hall J, Henk JM, Nutting CM, Harrington KJ. Definitive radiotherapy for extramedullary plasmacytomas of the head and neck. Br J Radiol. 2003;76:738-41.

50. Nutting CM, Normile PS, Bedford JL, Harrington KJ, Webb SA systematic study of techniques for elective cervical nodal irradiation with anterior or opposed anterior and posterior beams.Radiother Oncol. 2003;69:43-51.

51. C Nutting. Intensity-modulated radiotherapy (IMRT): the most important advance in radiotherapy since the linear accelerator? Br J Radiol. 2003;76:673

52. Padhani AR, Nutting CM. Why do we need more accurate intraprostatic localization of cancer? Br J Radiol. 2003;76:585-6.

53. C Nutting. Head and Neck cancer:Clinical and Translational approaches. Lancet 2003;361:2165

54. Clark CH, Miles EA, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM. In regard to Lee et al. Int J Radiat Oncol Biol Phys. 2003;55:1150

55. Westbury CB, Harrington KJ, Rhys-Evans P, Archer DJ, Searle AE, Henk JM, Black CM, Nutting CM. Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. Postgrad Med J. 2003;79:176-7.

56. McNair HA, Adams EJ, Clark CH, Miles EA, Nutting CM. Implementation of IMRT in the radiotherapy department. Br J Radiol. 2003;76:850-6.

57. Hall CE, Harris R, A'Hern R, Archer DJ, Rhys-Evans P, Henk JM, Harrington KJ, Nutting CM. Le Fort I osteotomy and low-dose rate Ir192 brachytherapy for treatment of recurrent nasopharyngeal tumours. Radiother Oncol. 2003;66:41-8.

58. Mendes RL, Nutting CM, Harrington KJ. Managing side effects of radiotherapy in head and neck cancer. Hosp Med. 2002;63:712-7

59. C Nutting, CM Corbishley, B Sanchez-Nieto, VP Cosgrove, S Webb, DP Dearnaley. Potential improvements in the therapeutic ratio of prostate cancer irradiation: Dose escalation of pathologically identified lesions using IMRT. British J Radiology 2002;75:151-61

60. C Nutting, JL Bedford, VP Cosgrove, DM Tait, DP Dearnaley, and S Webb. Intensity-modulated radiotherapy reduces lung irradiation in patients with carcinoma of the oesophagus. Front Radiat Ther Oncol 2002;37:128-31

61. C Nutting, JL Bedford, VP Cosgrove, DM Tait, DP Dearnaley, and S Webb. Radiotherapy for carcinoma of the oesophagus: A comparison of 3D conformal and intensity-modulated techniques. Radiother Oncol 2001;61:157-163

62. CG Rowbottom, C Nutting, S Webb. Beam-orientation optimisation of IMRT: Clinical application to parotid gland tumours.Radiother Oncol 2001;59:169-177

63. C Nutting, C Rowbottom, VP Cosgrove, JM Henk, DP Dearnaley, Robinson MH, Conway J, and S Webb. Optimisation of radiotherapy for carcinoma of the parotid gland: A comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol 2001;60:163-172

64. C Nutting and S Short on behalf of the Junior Radiologists Forum Executive: Where now with training in Clinical Oncology? Editorial for Clin Oncol 2001;13:4-5

65. Ahmad S, Nutting CM, Plowman PN. Orbital lymphoma treatment. Radiother Oncol 2001;61:101

66. C Nutting, DJ Convery, VP Cosgrove, L Vini, CL Harmer, DP Dearnaley, and S Webb. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland Radiother Oncol 2001;60:173-180

67. E J Adams, C Nutting, DJ Convery, VP Cosgrove, JM Henk, DP Dearnaley, S Webb. Potential role of intensity-modulated radiotherapy in the treatment of tumours of the maxillary sinus. Int J Radiat Oncol Biol Phys 2001;51:579-588

68. Violet J, Nutting C, Plowman PN, Britton KE. I123 imaging in the follow up of differentiated thyroid cancer. Clin Oncol 2001;13:313-4

69. C Nutting, VS Khoo, V Walker, H McNair, C Beardmore, A Norman, DP Dearnaley. A randomised trial of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol 2000;57:1-9

70. C Nutting, DP Dearnaley. Reply to Professor Fiorino regarding: A randomised trial of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol 2000;56:355-6

71. C Nutting, DJ Convery, VP Cosgrove, CG Rowbottom, AR Padhani, S Webb, DP Dearnaley. Reduction of small and large bowel irradiation using an optimised intensity-modulated pelvic radiotherapy technique (IMRT) in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:649-56

72. C Nutting, M Brada, L Brazil, A Sibtain, F Saran, C Westbury, D Traish, S Ashley, A Moore, DGT Thomas. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 1999;90(5):823-7

73. C Nutting, S Hyer, L Vini, C Harmer. Failure of TSH rise prior to radioiodine therapy for thyroid cancer: implications for treatment. Clin Oncol 1999;11:269-271

74. C Nutting, J Chowaniec. Evaluation of the actions and interactions of epidermal growth factor and retinoic acid on transformed urothelial cells in culture: Implications for the use of retinoid therapy in the treatment of bladder cancer patients. Clin Oncol 1992;4:51- 55

Back to top Δ

Review Articles

75. Kazi R, Prasad V, Nutting C, Rhys-Evans P, Harrington KJ. Are high-speed digital videoendoscopy systems the future of laryngology? Internet Journal of Otorhinolaryngology 2006;4:1-

76. Kazi R, De-Cordova J, Singh A, O’Leary L, Clarke P, Nutting C, Harrington KJ, Rhys-Evans P. Vocal rehabilitation following laryngectomy: Current trends and future perspectives. Internet Journal of Otorhinolaryngology 2006;4:2

77. Bhide SA, Harrington KJ, Nutting CM. Otological toxicity after postoperative radiotherapy for parotid tumours. Clin Oncol (R Coll Radiol). 2007;19:77-82

78. Newbold K, Partridge M, Cook G, Sohaib SA, Charles-Edwards E, Rhys-Evans P, Harrington KJ, Nutting C. Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. Br J Radiol. 2006;79:554-61

79. Rogers SJ, Box C, Harrington KJ, Nutting CM, Rhys-Evans P, Eccles SA. The phosphoinositide 3 kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. Expert Opin Ther Targets. 2005;9(4):769-90

80. Creak AL, Harrington KJ, Nutting CM. Recurrent head and neck cancer: Reirradiation or chemotherapy? Clin Oncol (R Coll Radiol). 2005;17(3):138-47.

81. Harrington KJ, Nutting CM, Pandha HS. Gene therapy for head and neck cancer. Cancer Metastasis Rev. 2005;24(1):147-64

82. Rogers SJ, Harrington KJ, Eccles SA, Nutting CM. Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC. Expert Rev Anticancer Ther. 2004 Aug;4(4):569-83.

83. Guerrero Urbano MT, Nutting CM. Clinical use of intensity-modulated radiotherapy: part I. Br J Radiol. 2004;77(914):88-96.

84. Guerrero Urbano MT, Nutting CM. Clinical use of intensity-modulated radiotherapy: part II. Br J Radiol. 2004;77(915):177-82.

85. Harrington KJ, Nutting CM. Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic Index? Curr Opin Investig Drugs. 2002;3:807-11

86. C Nutting, C Jenkins, A Norton, I Cree, GE Rose, PN Plowman. Primary orbital lymphoma. J Haematol 2002;3:14-6

87. C Nutting and DP Dearnaley. Prostate Cancer – The Royal Marsden Conformal Experience. Front Radiat Ther Oncol 2002;37:196-9

88. C Nutting and RA Huddart. The use of retinoids in the treatment of bladder cancer. Future Drugs 2002

89. K Harrington, C Nutting. Advances in therapy for head and neck cancer. Reviews in anti cancer therapy 2002

90. Nutting CM, Huddart RA. Retinoids in the prevention of bladder cancer. Expert Rev Anticancer Ther. 2001;1:541-5

91. C Nutting, DP Dearnaley, S Webb. Intensity Modulated Radiotherapy: A clinical review. Br J Radiology 2000;54:459-469

92. C Nutting, DP Dearnaley. Conformal Radiation therapy for prostate cancer. Urologic Oncology 2000

93. C Nutting, RA Huddart. Rethinking secondary prevention of superficial bladder cancer: Is there a role for retinoids? BJU International 2000;85:1023-1026

Back to top Δ

Case Reports

94. C Nutting, RS Camplejohn, R Gilchrist, D Tait, P Blake, G Knee, WQ Yao, G Ross, C Fisher, R Eeles. A patient with 17 primary tumours and a germ line mutation in TP53: Tumour induction by adjuvant therapy? Clin Oncol 2000;12:300-304

95. C Nutting, A Folkes. The use of raltitrexed in a patient with 5 FU - induced cardiac ischaemia (letter). Clinical Oncology 1999;11:66

96. C Nutting, A Horwich, C Fisher, C Parsons, D Dearnaley. Small cell carcinoma of the prostate. J R Soc Med 1997;90:340-341

97. C Nutting, SR Page. Iatrogenic Cushing's syndrome due to nasal betamethasone: a problem not to be sniffed at! Postgrad Med J 1995;71:231-2

Back to top Δ

Papers submitted and undergoing peer review

64. Guerrero Urbano MT, Henrys AJ, Adams E, Norman A, Bedford J, Harrington KJ, Nutting CM, Dearnaley DP, Tait DM. Intensity modulated radiotherapy (IMRT) in patients with locally advanced rectal cancer reduces the volume of bowel treated to high dose levels. Submitted to radiotherapy and Oncology 2005

65. Rogers SJ, Box C, Harrington KJ, Nutting CM, Rhys-Evans P, Eccles SA. Met and Ron: Receptor tyrosine kinase targets in the therapy of squamous cell carcinoma of the head and neck. Current Enzyme Inhibition 2005

66. Staffurth JN, Huddart RA, Convery DJ, Cosgrove VP, Clark CH, Adams EJ, McNair H, Bidmead M, Warrington AP, Nutting CM, Eeles R, Norman A, Sohaib SA, Horwich A, Webb S and Dearnaley DP. Intensity modulated radiotherapy in the management of locally advanced and node positive prostate cancer: preliminary report of a phase I study. IJROBP 2005

67. C Hector, PM Evans, S Webb, S Pradhan, C Nutting. The effect of Inter fraction organ motion on conventional, conformal and IMRT prostate treatments. Radiother Oncol 2005

68. Kirby A, Nutting C, Harrington KJ. Response rates to Irressa in squamous cell carcinoma of the head and neck. Submitted to Br J Cancer

69. Newbold K, Nutting C et al Application of Functional Imaging to head and neck radiotherapy planning. Submitted to Br J Radiol

70. Guerrero Urbano MT, Nutting C, et al. Role of MRI in treatment planning for head and neck cancer. Submitted to Radiotherapy and Oncology

71. Miles E, Nutting C et al. Implementation of IMRT at the Royal Marsden Hospital. Accepted for publication Radiotherapy and Oncology 2005

72. P Ross, L Pyle, RP A’Hern, P Rhys-Evans, D Archer, K Harrington, C Nutting, ME Gore. Epirubicin, Cisplatin and protracted infusion 5-fluorouracil for advanced salivary adenoid cystic carcinoma. Submitted JCO 2005

Back to top Δ

Chapters in books

98. Bhide S, Harrington KJ, Nutting CM. Radiation induced Xerostomia. In: Key Advances in Head and neck cancer. Eds Nutting, Miles, Bradley. Aesculapius Press

99. Bradley PJ, Zutshi B, Nutting CM. Developments in Clinical Resources Available for the Care of Head and Neck Cancer Patients in England. In: Key Advances in Head and neck cancer. Eds Nutting, Miles, Bradley. Aesculapius Press

100. Nutting C and Saunders M. Head and Neck Cancer. In Radiotherapy Planning Editor Hoskin.

101. Nutting C. Paranasal sinuses and Orbit. In Radiotherapy planning. Editor Huddart.

102. Harrington KJ, Nutting CM, Syrigos K. Prophylactic radiation for small cell lung cancer. In Lung cancer. Eds Nutting and Syrigos.

103. Newbold K and Nutting C. Radical radiotherapy for Lung Cancer. In Lung Cancer Editors Nutting and Syrigos

104. Newbold K and Nutting C. Palliative Radiotherapy for lung cancer. In Lung Cancer Editors Nutting and Syrigos.

105. Intra-prostatic boost: Emerging technology. Guerrero Urbano MT, Clark C, Nutting CM, Dearnaley DP. In: Intensity modulated radiation therapy: A clinical perspective. Eds AJ Mundt, JC Roeske, BC Decker. 2005 Chapter 22 472-476

106. Guerrero-Urbano T, and Nutting C. IMRT for carcinoma of the Larynx. In: IMRT Handbook:Concepts and clinical applications (Eds T Bortfeld, R Schmidt-Ullrich, W DeNeve. Publisher: Springer Verlag, Heildelberg).

107. B Sanchex-Nieto and C Nutting. Clinical application of biological models. In The practical use of TCP and NTCP models in the evaluation of treatment plans in radiotherapy. Eds G Gagliardi, M Cattameo and A Nahum Physica Medica vol XVII.supl 2: 86-92, 2001

108. C Nutting, D P Dearnaley. Neoadjuvant downstaging before radical radiotherapy. In: Bowsher WG (Editor). Challenges in Prostate Cancer. Chapman and Hall London. 2000

109. C Nutting, RA Huddart. Prostate cancer. In: Todd D (Editor). The National Association of Primary Care Official Review 1999. Scorpio Publishing, Surrey. 293-5

110. C Nutting, DP Dearnaley. External Beam radiotherapy in the management of localised prostate cancer. In: Syrigos K (Editor). Prostate Cancer: Biology, Diagnosis, and Management. Oxford University Press (in press) 2000

111. G Ross, ANJ Tutt, C Nutting. Indikationen und stellenwert strahlen-therapeutischer mabnahmen in der schmerztherapie bei tumorpatienten. In Interdisziplinare schmerztherapie bei tumourpatienten. Bartsch H H, von Hornstein W (Hrsg). Basel, Karger, 1998 p45-53

112. C Nutting, DP Dearnaley. Prostate Cancer. In: Gore M and Russell J (Editors). Cancer in General Practice. J Gregory Publications (in press) 2000

113. C Nutting, M Bidmead, KJ Harrington, and JM Henk. BIR Geometric uncertainties in radiotherapy: Head and neck cancer. In Geometric Uncertainties, A McKenzie Ed.

Books Edited

114. Lung Cancer: a multidisciplinary approach. Eds Nutting, Syrigos, Charalambous. Springer Verlag

115. Key Advances in Head and neck cancer. Eds Nutting, Miles, Bradley. Aesculapius Press

Back to top Δ

Abstracts

116. Guerrero Urbano MT, Henrys AJ, Adams E, Norman A, Bedford J, Harrington KJ, Nutting CM, Dearnaley DP, Tait DM. Rectal cancer: Can IMRT reduce the dose delivered to the bowel? Clinical Oncology 2005;17:S10

117. CH Clark MT Guerrero Urbano, EA Miles, AM Bidmead, KJ Harrington CM Nutting. Techniques to assist with inverse planning in advanced head and neck cancer. Clinical Oncology 2005;17:S10

118. Guerrero Urbano MT, Kong C, Burke K, Nalder C, Reinsberg S, Moore L, McNair H, Sohaib A, Harrington KJ and Nutting CM. Impact of MRI/CT co-registaration on radiotherapy planning of tumours located close to the base of skull.Radiotherapy and Oncology 2004 S442

119. CH Clark MT Guerrero Urbano, EA Miles, AM Bidmead, KJ Harrington CM Nutting. Techniques for inverse planning in advanced head and neck cancer. ESTRO Amsterdam October 2004

120. Guerrero Urbano MT, Kong C, Burke K, Nalder C, Reinsberg S, Moore L, McNair H, Sohaib A, Harrington KJ and Nutting CM. Impact of MRI/CT co-registaration on radiotherapy planning of tumours located close to the base of skull. Clinical Oncology 2004;16:S33

121. MT Guerrero Urbano, CH Clark, EA Miles, M Bidmead, EJ Adams, M Partridge, H McNair, C Harmer, K Harrington and CM Nutting. Phase I/II dose escalation study of intensity modulated radiotherapy (IMRT) in cancer of the thyroid, larynx and hypopharynx: report of acute toxicity. Clinical Oncology 16 (7) S9 October 2004

122. C H Clark, MT Guerrero Urbano, EA Miles, AM Bidmead and CM Nutting. Intensity modulation for parotid sparing in radiotherapy treatment of head and neck cancer: initial planning experience at the Royal Marsden, London. Clinical Oncology 16 (7) S3 October 2004

123. EA Miles C H Clark, MT Guerrero Urbano, DP. Dearnaley and CM Nutting. Intensity Modulated Radiotherapy in daily clinical practice for Head and Neck Cancer. Clinical Oncology 16 (7) S10 October 2004

124. T Guerrero Urbano, CH Clark, E Miles, M Bidmead, C Harmer, K Harrington, C Nutting. Phase I/II dose escalation study of intensity modulated radiotherapy (IMRT) in cancer of the thyroid, larynx and hypopharynx: A report of acute toxicity. ECCO 2003 EJC 2003;(1)N5 S39

125. EA Miles, CH Clark, MT Guerrero Urbano, DP Dearnaley and CM Nutting. How routine can IMRT become in daily clinical practice? ESTRO, Geneva September 2003

126. CH Clark, AM Bidmead, CD Mubata, KJ Harrington, P Rhys Evans and CM Nutting. Does IMRT provide an improved treatment for carcinoma of the larynx and cervical nodes? Clin Oncol 15 (2) Apr 2003 p S5 UKRO meeting Bath 7-9 April 2003

127. EA Miles, CH Clark, T Guerrero Urbano, DP Dearnaley and CM Nutting. How routine can IMRT become in daily clinical practice? Clin Oncol 15 (2) Apr 2003 p S30 UKRO meeting Bath 7-9 April 2003

128. T Guerrero Urbano, CH Clark, E Miles, K Harrington, C Nutting. Locally advanced head and neck cancer treated with intensity modulated radiotherapy: early report of acute toxicity. Clin Oncol 15 (2) Apr 2003 p S10 UKRO meeting Bath 7-9 April 2003

129. T Guerrero Urbano, CH Clark, E Miles, E Adams, M Partridge, H McNair, S Patel E Hall, K Harrington, C Nutting.A multicentre randomised study of parotid sparing Intensity Modulated Radiotherapy vs Conventional Radiotherapy in patients with Head and neck cancer. UKRO meeting Bath 7-9 April 2003

130. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Rhys Evans P Harmer C and Nutting CM. Does Intensity Modulated Radiotherapy (IMRT) provide an improved treatment for carcinoma of the larynx and cervical nodes. Meeting on Clinical IMRT in Europe Vienna November 2002

131. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Rhys Evans P Harmer C and Nutting CM. Planning and Quality Assurance Issues for Clinical Implementation of Intensity Modulated Radiotherapy (IMRT) for treatment of carcinoma of the larynx and cervical nodes. ESTRO Prague Sept 2002

132. Clark CH, Bidmead AM, Mubata CD, Humphreys ME, McNair H, Harrington KJ, Rhys Evans P, Harmer C and Nutting CM. Clinical Implementation of dynamic Intensity Modulated Radiotherapy for treatment of Thyroid cancer. Biennial IPEM Radiotherapy Southampton July 2002

133. Clark CH, Bidmead M, Harrington K, Rhys Evans P, Harmer C and Nutting C. Intensity-modulated radiotherapy for thyroid and laryngeal cancer: Evaluation and clinical implementation at the Royal Marsden NHS Trust. British Association of Head & Neck Oncologists London Apr 2002

134. Newbold et al Investigation of the role of integrated positron emission tomography and computed tomography (PETCT) in radiotherapy planning of head and neck cancer. Clinical Oncology 2004; 16: S4.3

135. C Hector, PM Evans, C Nutting, S Pradham, S Webb. Inter-fraction organ motion:The effect on Conventional Conformal, amd IMRT prostate treatments. UKRO

136. EA Miles, CH Clark, MT Guerrero-Urbano, DP Dearnaley, CM Nutting. How routine can IMRT become in daily clinical practice? UKRO 2003

137. J Chapman, VN Hansen, H McNair, J Balykyi, K Harrington, C Nutting. Implementation of 3D conformal radiotherapy for patients with head and neck cancer. BAHNO 2002 Abstract book

138. C Clark, M Bidmead, K Harrington, P Rhys Evans, C Harmer, C Nutting. Intensity-modulated radiotherapy for thyroid and laryngeal cancer: Implementation at the Royal marsden NHS Trust. BAHNO 2002 Abstract book

139. DS Hill, C Nutting, KJ Harrington, JM Henk, P Rhys Evans. Brachytherapy for recurrent SCC in the neck. BAHNO 2002 Abstract book

140. CEJ Hall, R Harris, R A’Hern, DJ Archer, P Rhys Evans, JM Henk, KJ Harrington, C Nutting. Le Fort Osteotomy and Low dose rate Ir192 Brachytherapy for treatment of recurrent nasopharyngeal tumours. BAHNO 2002 Abstract book

141. J Hall, C Nutting, JM Henk, KJ Harrington. Extramedullary plasmacytomas of the head and neck: the role of radiotherapy in their management. BAHNO 2002 Abstract book

142. V Cosgrove, DJ Convery, PS Murphy, C Nutting, S Webb. Dynamic MLC delivered IMRT: verification using Polyacrylamide gel dosimetry. In: Schlegal and Bortfeld (Editors). The use of computers in radiotherapy. Proceedings of XIII International Conference. Springer-Verlag, Berlin. 2000 p311-313

143. C Nutting, D Convery, V Cosgrove, C Rowbottom, A Padhani, S Webb, and DP Dearnaley. Reduction in small and large bowel irradiation using an optimised intensity-modulated pelvic radiotherapy technique (IMRT) in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000;46:750

144. C Rowbottom, C Nutting, S Webb. Optimisation of beam-orientations in IMRT treatment planning of head and neck tumours. Int J Radiat Oncol Biol Phys 2000;46:749

145. C Nutting, VS Khoo, V Walker, H McNair, C Beardmore, A Norman, DP Dearnaley. A customised immobilisation system for prostate cancer radiotherapy: A randomised trial. Clin Oncol 2000;12:65

146. C Nutting, J Bedford, V Cosgrove, S Webb, DP Dearnaley, D Tait. Radiotherapy for carcinoma of the oesophagus: A comparison of 3D conformal and IMRT techniques. Radiother Oncol 2000 (in press)

147. C Nutting, CG Rowbottom , S Webb. Improving efficiency of intensity modulated radiotherapy: an algorithm for optimisation of beam orientation. Br J Radiol 2000;72(Suppl):93

148. C Nutting, C Rowbottom, D Convery, V Cosgrove, DP Dearnaley, C Harmer, JM Henk, S Webb. Intensity modulated radiotherapy in tumours of the head and neck. Br J Radiology 1999;72:98-99

149. C Nutting, V Khoo, V Walker, A Norman, D P Dearnaley. A prospective randomised trial of a customised immobilisation system for conformal prostate cancer radiotherapy. Br J Cancer 1999:80;59

150. C Nutting, V Khoo, V Walker, A Norman, DP Dearnaley. The use of an immobilisation system in the tratment of prostate cancer with conformal radiotherapy-A prospective randomised trial. EJC 1999:35;S95

151. C Nutting, D Convery, C Rowbottom, V Cosgrove, DP Dearnaley, JM Henk, C Harmer, S Webb. Intensity modulated radiotherapy for carcinoma of the thyroid and parotid gland. EJC 1999:35;S96

152. C Nutting, L Brazil, J Steel, H Alheit, D Traish, S Ashley, M Brada. Benign meningioma of the skull base. Br J Cancer 1997;76 Suppl 1:50

153. CA Parry, C Nutting, J Chowaniec. Modulation of expression of the transformed phenotype of bladder cancer cells by epidermal growth factor and retinoic acid. J Pathol 1990;160(2):162.

154. C Nutting, D Convery, V Cosgrove, C Rowbottom, S Webb, and D Dearnaley. Intensity-modulated radiotherapy (IMRT) for tumours of the head and neck, pelvis, and thorax: Pre-clinical evaluation and implementation. Br J Cancer 2000;83 (Suppl 1):26

155. C Nutting, CA Parry, J Chowaniec. The actions and interactions of retinoic acid and epidermal growth factor on the transformed phenotype of bladder cancer cells in vitro. Uro-oncology 1990 p27

156. EJ Adams, DJ Convery, C Nutting, AP Warrington, S Webb. Initial experiences with Helax-TMS for planning of IMRT treatments. Radiother Oncol 2000;56:S213-214

157. C Nutting, D Convery, V Cosgrove, C Rowbottom, S Webb, and D Dearnaley. Evaluation of Intensity-modulated radiotherapy for tumours of the pelvis, head and neck, and thorax: Optimisation and clinical implementation. Int J Radiat Oncol Biol Phys 2000;48(3):139

Back to top Δ

Others

158. C Nutting. Cancer. Principles and practice of Oncology (book review) Br J Radiology 2002;75:567

159. C Nutting on behalf of the Junior Radiologists Forum Executive: Results of the Junior Radiologists Forum Training Questionnaire 1999. Royal College of Radiologists Newsletter

160. C Nutting. An evaluation of the cost-effectiveness of palliative chemotherapy in the treatment of advanced malignancy. A Thesis for the Management School, Imperial College of Science, Technology and Medicine.

Back to top Δ

Patient Treatment

Treatments

Learn about our specialisms and world leading cancer treatments:

Clinical Team

Here for you

Prof Nutting treats both private and NHS patients, learn about the practice and Prof Nutting's clinical teams here.

patient consultation

Arrange a Consultation

Complete our simple contact form
to get in touch.